Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Sleep and Breathing
Published in: Sleep and Breathing 3/2013

01-09-2013 | Original Article

Sleep-disordered breathing and daytime napping are associated with maternal hyperglycemia

Authors: Bilgay Izci Balserak, Nicholas Jackson, Sarah A. Ratcliffe, Allan I. Pack, Grace W. Pien

Published in: Sleep and Breathing | Issue 3/2013

Login to get access

Abstract

Objectives

Sleep disturbances in pregnancy may impair glucose mechanism. This study aimed to examine associations of sleep-disordered breathing, sleep, and nap duration with 1-h glucose challenge test (GCT) levels in pregnant women after controlling for known risk factors for gestational diabetes.

Methods

This is a case–control study of 104 pregnant women. All women underwent full polysomnography and a GCT and completed the multivariable apnea prediction and Pittsburgh Sleep Quality indexes. The primary outcome was maternal hyperglycemia measured by GCT. Bivariate and multivariable logistic regression analyses were performed.

Results

Over 13 % subjects reported habitual snoring in the first trimester. Only 9.3 % women with normoglycemia (GCT < 135) were habitual snorers, whereas 45.5 % women with hyperglycemia (GCT ≥ 135) had habitual snoring (p < 0.001). Sleep-disordered breathing symptoms (loud snoring, snorting/gasping, and apneas) (odds ratio (OR) 2.85; 95 % confidence interval (CI) 1.50–5.41; p = 0.001) and total nap duration (OR 1.48; 95 % CI 0.96–2.28; p = 0.08) were associated with hyperglycemia. After adjusting for confounders, sleep-disordered breathing symptoms (OR 3.37; 95 % CI 1.44–8.32; p = 0.005) and nap duration (OR 1.64; 95 % CI 1.00–2.681.02; p = 0.05) continued to be associated with hyperglycemia. However, the primary exposure measure, the apnea/hypopnea index in the first trimester was not significantly associated with hyperglycemia (OR 1.03; 95 % CI 0.83–1.28; p = 0.77).

Conclusions

Sleep-disordered breathing symptoms and nap duration are associated with hyperglycemia. Sleep duration was not associated with hyperglycemia. Research is needed concerning whether women with sleep-disordered breathing and/or daytime napping are at risk for gestational diabetes.
Literature
1.
Gottlieb DJ, Punjabi NM, Newman AB, Resnick HE, Redline S, Baldwin CM, Nieto FJ (2005) Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med 165(8):863–867PubMedCrossRef
2.
Elmasry A, Janson C, Lindberg E, Gislason T, Tageldin MA, Boman G (2000) The role of habitual snoring and obesity in the development of diabetes: a 10-year follow-up study in a male population. J Int Med 248(1):13–20CrossRef
3.
Ayas NT, White DP, Al-Delaimy WK, Manson JE, Stampfer MJ, Speizer FE, Patel S, Hu FB (2003) A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care 26(2):380–384PubMedCrossRef
4.
Al-Delaimy WK, Manson JE, Willett WC, Stampfer MJ, Hu FB (2002) Snoring as a risk factor for type II diabetes mellitus: a prospective study. Am J Epidemiol 155(5):387–393PubMedCrossRef
5.
Botros N, Concato J, Mohsenin V, Selim B, Doctor K, Yaggi HK (2009) Obstructive sleep apnea as a risk factor for type 2 diabetes. Am J Med 122(12):1122–1127PubMedCrossRef
6.
Punjabi NM, Shahar E, Redline S, Gottlieb DJ, Givelber R, Resnick HE, Sleep Heart Health Study I (2004) Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 160(6):521–530PubMedCrossRef
7.
Tasali E, Van Cauter E, Hoffman L, Ehrmann DA (2008) Impact of obstructive sleep apnea on insulin resistance and glucose tolerance in women with polycystic ovary syndrome. J Clin Endocrinol Metab 93(10):3878–3884PubMedCrossRef
8.
Valham F, Stegmayr B, Eriksson M, Hagg E, Lindberg E, Franklin KA (2009) Snoring and witnessed sleep apnea is related to diabetes mellitus in women. Sleep Med 10(1):112–117PubMedCrossRef
9.
Tasali E, Mokhlesi B, Van Cauter E (2008) Obstructive sleep apnea and type 2 diabetes: interacting epidemics. Chest 133(2):496–506PubMedCrossRef
10.
Pien GW, Fife D, Pack AI, Nkwuo JE, Schwab RJ (2005) Changes in symptoms of sleep-disordered breathing during pregnancy. Sleep 28(10):1299–1305PubMed
11.
Bixler EO, Vgontzas AN, Lin HM, Ten Have T, Rein J, Vela-Bueno A, Kales A (2001) Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med 163(3 Pt 1):608–613PubMedCrossRef
12.
Okun ML, Hall M, Coussons-Read ME (2007) Sleep disturbances increase interleukin-6 production during pregnancy: implications for pregnancy complications. Reprod Sci 14(6):560–567PubMedCrossRef
13.
Izci-Balserak B (2008) Sleep-disordered breathing in pregnancy. Int J Sleep Wakefulness 1(3):98–108
14.
Lee KA, Zaffke ME, McEnany G (2000) Parity and sleep patterns during and after pregnancy. Obstet Gynecol 95(1):14–18PubMedCrossRef
15.
Izci B, Vennelle M, Liston WA, Dundas KC, Calder AA, Douglas NJ (2006) Sleep-disordered breathing and upper airway size in pregnancy and post-partum. Eur Respir J 27(2):321–327PubMedCrossRef
16.
Izci-Balserak B, Lee KA (2010) Sleep disturbances and sleep-related disorders in pregnancy. In: Kryger M, Roth T, Dement W (eds) Principles and practice of sleep medicine, vol 5th. Saunders, Philadelphia, pp 1572–1586
17.
Facco FL, Grobman WA, Kramer J, Ho KH, Zee PC (2010) Self-reported short sleep duration and frequent snoring in pregnancy: impact on glucose metabolism. Am J Obstet Gynecol 203(2):142, e141-145PubMedCrossRef
18.
Bourjeily G, Raker CA, Chalhoub M, Miller MA (2010) Pregnancy and fetal outcomes of symptoms of sleep-disordered breathing. Eur Respir J 36(4):849–855PubMedCrossRef
19.
Cai XH, Xie YP, Li XC, Qu WL, Li T, Wang HX, Lv JQ, Wang LX (2012) The prevalence and associated risk factors of sleep disorder-related symptoms in pregnant women in China. Sleep Breath. doi:10.​1007/​s11325-012-0783-2
20.
Frederick IO, Qiu C, Sorensen TK, Enquobahrie DA, Williams MA (2013) The prevalence and correlates of habitual snoring during pregnancy. Sleep Breath. doi:10.​1007/​s11325-012-0717-z
21.
Williams MA, Miller RS, Qiu C, Cripe SM, Gelaye B, Enquobahrie D (2010) Associations of early pregnancy sleep duration with trimester-specific blood pressures and hypertensive disorders in pregnancy. Sleep 33(10):1363–1371PubMed
22.
Izci B, Riha RL, Martin SE, Vennelle M, Liston WA, Dundas KC, Calder AA, Douglas NJ (2003) The upper airway in pregnancy and pre-eclampsia. Am J Respir Crit Care Med 167(2):137–140PubMedCrossRef
23.
Sahin FK, Koken G, Cosar E, Saylan F, Fidan F, Yilmazer M, Unlu M (2008) Obstructive sleep apnea in pregnancy and fetal outcome. Int J Obstet Gynecol 100(2):141–146CrossRef
24.
Micheli K, Komninos I, Bagkeris E, Roumeliotaki T, Koutis A, Kogevinas M, Chatzi L (2011) Sleep patterns in late pregnancy and risk of preterm birth and fetal growth restriction. Epidemiology 22(5):738–744PubMedCrossRef
25.
Qiu C, Enquobahrie D, Frederick IO, Abetew D, Williams MA (2010) Glucose intolerance and gestational diabetes risk in relation to sleep duration and snoring during pregnancy: a pilot study. BMC women's health 10:17PubMedCrossRef
26.
Champagne K, Schwartzman K, Opatrny L, Barriga P, Morin L, Mallozzi A, Benjamin A, Kimoff RJ (2009) Obstructive sleep apnoea and its association with gestational hypertension. Eur Respir J 33(3):559–565PubMedCrossRef
27.
Moore RT (2004) Diabetes in pregnancy. In: Creasy RK, Resnik R, Lams JD (eds) Maternal-fetal medicine: principles and practice, 5th edn. W. B. Saunders, Philadelphia, pp 1023–1062
28.
Group HSCR, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, Hadden DR, McCance DR, Hod M, McIntyre HD, Oats JJ, Persson B, Rogers MS, Sacks DA (2008) Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358(19):1991–2002PubMedCrossRef
29.
Simeoni U, Barker DJ (2009) Offspring of diabetic pregnancy: long-term outcomes. Semin Fetal Neonatal Med 14(2):119–124PubMedCrossRef
30.
Herring SJ, Oken E, Rifas-Shiman SL, Rich-Edwards JW, Stuebe AM, Kleinman KP, Gillman MW (2009) Weight gain in pregnancy and risk of maternal hyperglycemia. Am J Obstet Gynecol 201(1):61.e61–61.e67CrossRef
31.
Metzger BE, Buchanan TA, Coustan DR, de Leiva A, Dunger DB, Hadden DR, Hod M, Kitzmiller JL, Kjos SL, Oats JN, Pettitt DJ, Sacks DA, Zoupas C (2007) Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care 30(Suppl 2):S251–S260PubMedCrossRef
32.
Tasali E, Leproult R, Spiegel K (2009) Reduced sleep duration or quality: relationships with insulin resistance and type 2 diabetes. Prog Cardiovasc Dis 51(5):381–391PubMedCrossRef
33.
Codario RA (2005) Type 2 diabetes, pre-diabetes, and the metabolic syndrome: the primary care guide to diagnosis and management. Current clinical practice. Humana Press, TotowaCrossRef
34.
Maislin G, Pack AI, Kribbs NB, Smith PL, Schwartz AR, Kline LR, Schwab RJ, Dinges DF (1995) A survey screen for prediction of apnea. Sleep 18(3):158–166PubMed
35.
Jomeen J, Martin CR (2007) Assessment and relationship of sleep quality to depression in early pregnancy. J Psychosom Res 25:87–99
36.
Chen YH, Kang JH, Lin CC, Wang IT, Keller JJ, Lin HC (2012) Obstructive sleep apnea and the risk of adverse pregnancy outcomes. Am J Obstet Gynecol 206(2):136, e131-135PubMedCrossRef
37.
O'Brien LM, Bullough AS, Owusu JT, Tremblay KA, Brincat CA, Chames MC, Kalbfleisch JD, Chervin RD (2012) Pregnancy-onset habitual snoring, gestational hypertension, and preeclampsia: prospective cohort study. Am J Obstet Gynecol 207(6):487, e481-489PubMedCrossRef
38.
Aronsohn RS, Whitmore H, Van Cauter E, Tasali E (2010) Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes. Am J Respir Crit Care Med 181(5):507–513PubMedCrossRef
39.
Izci-Balserak B, Pien GW (2010) Sleep-disordered breathing and pregnancy: potential mechanisms and evidence for maternal and fetal morbidity. Curr Opin Pulm Med 16(6):574–582PubMedCrossRef
40.
Tasali E, Leproult R, Spiegel K (2009) Reduced sleep duration or quality: relationships with insulin resistance and type 2 diabetes. Prog Cardiovasc Dis 51(5):381–391PubMedCrossRef
41.
Punjabi NM, Beamer BA (2009) Alterations in glucose disposal in sleep-disordered breathing. Am J Respir Crit Care Med 179(3):235–240PubMedCrossRef
42.
Connolly G, Razak AR, Hayanga A, Russell A, McKenna P, McNicholas WT (2001) Inspiratory flow limitation during sleep in pre-eclampsia: comparison with normal pregnant and nonpregnant women. Eur Respir J 18(4):672–676PubMedCrossRef
43.
Edwards N, Blyton DM, Kirjavainen T, Kesby GJ, Sullivan CE (2000) Nasal continuous positive airway pressure reduces sleep-induced blood pressure increments in preeclampsia. Am J Respir Crit Care Med 162(1):252–257PubMedCrossRef
44.
Guilleminault C, Palombini L, Poyares D, Takaoka S, Huynh NTL, El-Sayed Y (2007) Pre-eclampsia and nasal CPAP: part 1. Early intervention with nasal CPAP in pregnant women with risk-factors for pre-eclampsia: preliminary findings. Sleep Med 9(1):9–14PubMedCrossRef
45.
Poyares D, Guilleminault C, Hachul H, Fujita L, Takaoka S, Tufik S, Sass N (2007) Pre-eclampsia and nasal CPAP: part 2. Hypertension during pregnancy, chronic snoring, and early nasal CPAP intervention. Sleep Med 9(1):15–21PubMedCrossRef
46.
Foster GD, Sanders MH, Millman R, Zammit G, Borradaile KE, Newman AB, Wadden TA, Kelley D, Wing RR, Sunyer FX, Darcey V, Kuna ST, Sleep ARG (2009) Obstructive sleep apnea among obese patients with type 2 diabetes. Diabetes Care 32(6):1017–1019PubMedCrossRef
47.
Louis J, Auckley D, Miladinovic B, Shepherd A, Mencin P, Kumar D, Mercer B, Redline S (2012) Perinatal outcomes associated with obstructive sleep apnea in obese pregnant women. Obstet Gynecol 120(5):1085–1092PubMed
48.
Lam KH, Jiang CQ, Thomas GN, Lao XQ, McGhee SM, Zhang WS, Schooling CM, Adab P, Cheng KK, Arora T, Taheri S, Lam TH (2010) Napping is associated with increased risk of type 2 diabetes: the Guangzhou Biobank Cohort Study. Sleep 33(3):402–407PubMed
49.
Xu Q, Song Y, Hollenbeck A, Blair A, Schatzkin A, Chen H (2010) Day napping and short night sleeping are associated with higher risk of diabetes in older adults. Diabetes Care 33(1):78–83PubMedCrossRef
50.
Mallon L, Broman JE, Hetta J (2005) High incidence of diabetes in men with sleep complaints or short sleep duration: a 12-year follow-up study of a middle-aged population. Diabetes Care 28(11):2762–2767PubMedCrossRef
Metadata
Title
Sleep-disordered breathing and daytime napping are associated with maternal hyperglycemia
Authors
Bilgay Izci Balserak
Nicholas Jackson
Sarah A. Ratcliffe
Allan I. Pack
Grace W. Pien
Publication date
01-09-2013
Publisher
Springer Berlin Heidelberg
Published in
Sleep and Breathing / Issue 3/2013
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-013-0809-4

Other articles of this Issue 3/2013

Sleep and Breathing 3/2013 Go to the issue

EDITORIAL (Invited)

Regular physical exercise: evidence for health benefits in OSA patients?

Original Article

Assessment of the uvulo-glossopharyngeal dimensions in patients with β-thalassemia major

Original Article

Acute sleep deprivation in healthy adults is associated with a reduction in left atrial early diastolic strain rate

Original Article

Psychosomatic symptom profiles in patients with restless legs syndrome

Original Article

Serum EPO and VEGF levels in patients with sleep-disordered breathing and acute myocardial infarction

Original Article

Sleep quality and sleep patterns in relation to consumption of energy drinks, caffeinated beverages, and other stimulants among Thai college students
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits